Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02892773 · ClinicalTrials.gov registry record · NA

Comparing the Effectiveness of Lung Expansion Therapy in Adult Human Subjects

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
112
Enrollment target

NCT02892773 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 112 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02892773, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target

Study Summary

The purpose of this study is to better understand how air is spread throughout study participants' lungs after abdominal surgery by comparing two lung inflation treatments: 1. Incentive Spirometry (I.S.) lung expansion therapy 2. EzPAP® lung expansion therapy. Lung expansion therapy is routinely used after upper abdominal surgery. Taking deep breaths after surgery helps lungs to stay inflated. At the University of Virginia, it is at the physician's discretion as to which treatment will be used to help with deep breathing lung inflation therapy after surgery. The investigators would like to know which of the lung inflation therapies is better at helping inflate participants' lungs. The investigators will be using a device called Electrical Impedance Tomography (EIT) to measure how effectively air spreads in participants' lungs. This device is not currently approved by the Food and Drug Administration (FDA) for the purpose used in this study, and therefore, it is considered investigational. Investigators are inviting eligible participants to consider participating in this study because doctors order Incentive Spirometry as a standard of care following upper abdominal surgery. Information gained from monitoring how air is spread throughout participants' lungs will help investigators to determine if there is a clinical difference and benefit when comparing Incentive Spirometry and EzPAP lung expansion therapies.

Interventions

  • DEVICE Incentive Spirometry
  • DEVICE EzPAP® Positive Airway Pressure

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2017-01
Est. Completion 2018-11-12
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT02892773

The ClinicalTrials.gov registry entry for NCT02892773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Incentive Spirometry is the first listed.

NCT02892773 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02892773 about?

NCT02892773 is a clinical study titled "Comparing the Effectiveness of Lung Expansion Therapy in Adult Human Subjects". The purpose of this study is to better understand how air is spread throughout study participants' lungs after abdominal surgery by comparing two lung inflation treatments: 1. Incentive Spirometry (I.S.) lung expansion therapy 2. EzPAP® lung expansion therapy. Lung expansion therapy is routinely u...

What is the current status of trial NCT02892773?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2017-01. Estimated completion is 2018-11-12.

What interventions are being tested in trial NCT02892773?

The interventions under investigation include: Incentive Spirometry (DEVICE), EzPAP® Positive Airway Pressure (DEVICE).

Who is sponsoring clinical trial NCT02892773?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.